These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10792268)

  • 21. Hydroxyurea for sickle-cell anaemia in Africa: mind the gap.
    Obaro SK
    Lancet Glob Health; 2015 Mar; 3(3):e124-5. PubMed ID: 25701988
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.
    Ware RE; Zimmerman SA; Sylvestre PB; Mortier NA; Davis JS; Treem WR; Schultz WH
    J Pediatr; 2004 Sep; 145(3):346-52. PubMed ID: 15343189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI abnormalities in infants with sickle cell anemia-indication for preemptive therapy?
    Ozsahin H
    Pediatr Blood Cancer; 2008 Nov; 51(5):573-4. PubMed ID: 18623220
    [No Abstract]   [Full Text] [Related]  

  • 24. Sickle cell disease.
    McCavit TL
    Pediatr Rev; 2012 May; 33(5):195-204; quiz 205-6. PubMed ID: 22550263
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia.
    Eggleston B; Patience M; Edwards S; Adamkiewicz T; Buchanan GR; Davies SC; Dickerhoff R; Donfield S; Feig SA; Giller RH; Haight A; Horan J; Hsu LL; Kamani N; Lane P; Levine JE; Margolis D; Moore TB; Ohene-Frempong K; Redding-Lallinger R; Roberts IA; Rogers ZR; Sanders JE; Scott JP; Sleight B; Thompson AA; Sullivan KM; Walters MC;
    Br J Haematol; 2007 Feb; 136(4):673-6. PubMed ID: 17223910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of sickle cell disease.
    Steinberg MH
    N Engl J Med; 1999 Apr; 340(13):1021-30. PubMed ID: 10099145
    [No Abstract]   [Full Text] [Related]  

  • 27. Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort.
    Lagunju I; Brown BJ; Sodeinde O
    Pediatr Blood Cancer; 2015 Sep; 62(9):1587-91. PubMed ID: 25847050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic challenges in childhood sickle cell disease. Part 2: a problem-orientated approach.
    Amrolia PJ; Almeida A; Davies SC; Roberts IA
    Br J Haematol; 2003 Mar; 120(5):737-43. PubMed ID: 12614203
    [No Abstract]   [Full Text] [Related]  

  • 29. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.
    Chaturvedi S; DeBaun MR
    Am J Hematol; 2016 Jan; 91(1):5-14. PubMed ID: 26547630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trial.
    Wood JC; Pressel S; Rogers ZR; Odame I; Kwiatkowski JL; Lee MT; Owen WC; Cohen AR; St Pierre T; Heeney MM; Schultz WH; Davis BR; Ware RE;
    Am J Hematol; 2015 Sep; 90(9):806-10. PubMed ID: 26087998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New treatments of sickle cell disease.
    Embury SH
    West J Med; 1996 May; 164(5):444. PubMed ID: 8686307
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial.
    Wang WC; Morales KH; Scher CD; Styles L; Olivieri N; Adams R; Brambilla D;
    J Pediatr; 2005 Aug; 147(2):244-7. PubMed ID: 16126058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
    Sumoza A; de Bisotti R; Sumoza D; Fairbanks V
    Am J Hematol; 2002 Nov; 71(3):161-5. PubMed ID: 12410569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary benefit of maintaining normal transcranial Doppler velocities when using hydroxyurea for prevention of severe sickle cell anemia.
    Ghafuri DL; Chaturvedi S; Rodeghier M; Stimpson SJ; McClain B; Byrd J; DeBaun MR
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sickle cell disease in North Europe.
    Howard J; Davies SC
    Scand J Clin Lab Invest; 2007; 67(1):27-38. PubMed ID: 17365983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stroke in patients with sickle cell disease.
    Webb J; Kwiatkowski JL
    Expert Rev Hematol; 2013 Jun; 6(3):301-16. PubMed ID: 23782084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results and current indications of bone marrow allograft in sickle cell disease].
    Bernaudin F
    Pathol Biol (Paris); 1999 Jan; 47(1):59-64. PubMed ID: 10081781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management.
    Lê PQ; Ferster A; Cotton F; Vertongen F; Vermylen C; Vanderfaeillie A; Dedeken L; Heijmans C; Ketelslegers O; Dresse MF; Gulbis B
    Med Trop (Mars); 2010 Dec; 70(5-6):467-70. PubMed ID: 21516988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of cerebral vasculopathy in sickle cell disease using transcranial Doppler ultrasonography and magnetic resonance imaging. Case report.
    Adams RJ; Aaslid R; el Gammal T; Nichols FT; McKie V
    Stroke; 1988 Apr; 19(4):518-20. PubMed ID: 3284018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow transplantation in sickle-cell anemia in Pesaro.
    Giardini C; Galimberti M; Lucarelli G; Polchi P; Angelucci E; Baronciani D; Agostinelli F; Giorgi C; Muretto P
    Bone Marrow Transplant; 1993; 12 Suppl 1():122-3. PubMed ID: 8374552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.